-
公开(公告)号:EP2582364A2
公开(公告)日:2013-04-24
申请号:EP11726705.4
申请日:2011-06-15
发明人: HORSTMANN, Michael , EIFLER, René , KAUFMANN, Regine , MOHR, Patrick , GALIA, Eric , PRANGE, Wolfgang , BULLER, Stefan , PUSECKER, Klaus , STAMPFUSS, Jan , STOELBEN, Susanne
CPC分类号: A61K9/7053 , A61K9/7061 , A61K31/13
摘要: The invention relates to transdermal therapeutic systems (TTS) which contain as active substance the NMDA receptor antagonist memantine or one of its physiologically acceptable salts. The TTS can be prepared and employed for the treatment of diseases of the central nervous system.
-
公开(公告)号:EP2582364B1
公开(公告)日:2019-05-01
申请号:EP11726705.4
申请日:2011-06-15
-
3.TRANSDERMALES THERAPEUTISCHES SYSTEM MIT GESTEUERTEM WIRKSTOFFFLUSS, DAS EIN BASISCH REAGIERENDES OXID ENTHÄLT 审中-公开
标题翻译: 转基因治疗系统麻醉剂GESTEUERTEM WIRKSTOFFFLUSS,DAS EIN BASISCH REAGIERENDES OXIDENTHÄLT公开(公告)号:EP2435082A1
公开(公告)日:2012-04-04
申请号:EP10720724.3
申请日:2010-05-19
发明人: EIFLER, René , KAUFMANN, Regine , MOHR, Patrick
CPC分类号: A61K9/7061 , A61K31/13 , A61K47/02 , Y10T156/10
摘要: The present invention relates to transdermal therapeutic systems, comprising an occlusive back layer impervious to an active substance, a single or multilayer matrix, and a peelable protective film, wherein the matrix or at least one of the matrix layers comprises a pharmaceutical active substance or a plurality of pharmaceutical active substances in the form of at least one pharmaceutically consumable salt thereof, and a pharmaceutically consumable, alkaline reacting oxide.
摘要翻译: 本发明涉及透皮治疗系统,其包括不透过活性物质的闭合背层,单层或多层基质和可剥离保护膜。 基质或基质层中的至少一个包括药物活性物质或其至少一种药学上可食用的盐和药学上可消耗的碱性反应氧化物形式的多种药物活性物质。
-
公开(公告)号:EP3678647A1
公开(公告)日:2020-07-15
申请号:EP18762308.7
申请日:2018-09-04
-
公开(公告)号:EP3764997A1
公开(公告)日:2021-01-20
申请号:EP19709058.2
申请日:2019-03-11
发明人: EMGENBROICH, Marco , WAUER, Gabriel , LINN, Michael , BÖHM, Rolf , SCHMITZ, Christoph , KAUFMANN, Regine , WOLF, Hans-Werner , REUM, Nico , SCHLÜTER, Anna
IPC分类号: A61K9/70 , A61K31/485 , A61P25/04
-
公开(公告)号:EP3764996A1
公开(公告)日:2021-01-20
申请号:EP19708861.0
申请日:2019-03-11
发明人: EMGENBROICH, Marco , WAUER, Gabriel , LINN, Michael , BÖHM, Rolf , SCHMITZ, Christoph , KAUFMANN, Regine , WOLF, Hans-Werner , REUM, Nico , SCHLÜTER, Anna
IPC分类号: A61K9/70 , A61K31/465 , A61P25/16 , A61P25/28 , A61P25/26 , A61K31/27 , A61K31/485 , A61P25/04
-
公开(公告)号:EP3764998A1
公开(公告)日:2021-01-20
申请号:EP19709060.8
申请日:2019-03-11
发明人: EMGENBROICH, Marco , WAUER, Gabriel , LINN, Michael , BÖHM, Rolf , SCHMITZ, Christoph , KAUFMANN, Regine , WOLF, Hans-Werner , REUM, Nico , SCHLÜTER, Anna
IPC分类号: A61K9/70 , A61K31/465 , A61P25/16 , A61P25/28 , A61P25/26 , A61K31/27 , A61K31/485 , A61P25/04
-
8.
公开(公告)号:EP1651215A1
公开(公告)日:2006-05-03
申请号:EP04740987.5
申请日:2004-07-14
IPC分类号: A61K31/428 , A61K9/70
CPC分类号: A61K9/7061 , A61K31/428
摘要: The invention relates to a transdermal therapeutic system (TTS) releasing an active pramipexol agent during a time ranging from 4 to 7 hours.
-
-
-
-
-
-
-